Do Not Give Indomethacin and Ketorolac Together
Indomethacin and ketorolac (Toradol) should NOT be administered at the same time. This combination is explicitly contraindicated due to the significantly increased risk of serious gastrointestinal bleeding, renal toxicity, and other NSAID-related adverse events.
Why This Combination Is Dangerous
Both indomethacin and ketorolac are nonselective NSAIDs that work through the same mechanism—inhibiting cyclooxygenase (COX) enzymes and blocking prostaglandin synthesis. Using them together provides:
- No additional therapeutic benefit (they work via identical pathways)
- Multiplicative toxicity risk rather than additive analgesia
- Dramatically increased bleeding risk 1
Specific Risks of Concurrent NSAID Use
The FDA drug label for ketorolac explicitly warns about concurrent NSAID use 2:
- Gastrointestinal bleeding risk increases >10-fold when combining NSAIDs compared to single-agent use 1
- Both indomethacin and ketorolac are among the highest-risk NSAIDs for GI toxicity due to their prolonged half-lives and significant enterohepatic circulation 1
- Renal toxicity is compounded—both drugs inhibit renal prostaglandins critical for maintaining renal perfusion 2
- Bleeding complications are magnified as both drugs affect platelet aggregation 2
Clinical Guideline Perspective
Guidelines emphasize that concurrent use of multiple NSAIDs, including over-the-counter products, is a major risk factor for serious GI complications 1. The risk stratification is clear:
- History of previous ulcer or GI bleeding (odds ratio up to 13.5)
- Combination NSAID use (including aspirin)
- Advanced age
- High-dose or prolonged NSAID therapy
What To Do Instead
If a patient requires stronger analgesia than a single NSAID provides:
Optimize the single NSAID: Use the maximum effective dose of ONE agent (either indomethacin OR ketorolac, not both)
Add a different class of analgesic:
- Opioids (if appropriate for pain severity)
- Acetaminophen (different mechanism, can be combined safely)
- Regional anesthesia techniques when applicable
For ketorolac specifically: Remember the 5-day maximum duration limit 2—this drug is intended for short-term acute pain management only
Consider GI prophylaxis: If NSAID use is necessary in high-risk patients, add a proton pump inhibitor 1
Common Pitfall to Avoid
Do not assume that using different routes of administration makes this combination safe. Whether given IV, IM, PO, or rectally, both drugs achieve systemic levels and the risks remain 3, 4. The research showing equivalent efficacy between ketorolac and indomethacin 3, 4 actually reinforces that there's no reason to combine them—they're interchangeable, not complementary.
Bottom Line
This is a hard stop. There is no clinical scenario where combining these two NSAIDs is appropriate. Choose one agent, optimize its dosing, and add analgesics from different drug classes if needed.